(Q36746447)

English

Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review.

scientific article published on February 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: a study of 25 consecutive patients and a literature review (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Ibrahim Yakoub-Agha

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

J B Micol

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

C Berthon

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

S Tricot

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

S Darré

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

P Cracco

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

F Boulanger

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

F Bauters

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

J P Jouet

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 February 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Leukemia & Lymphoma

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

48

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

321-329

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Graft-versus-tumor effects after allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Related and unrelated nonmyeloablative hematopoietic stem cell transplantation for malignant diseases

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Bl

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Rapid establishment of long-term culture-initiating cells of donor origin after nonmyeloablative allogeneic hematopoietic stem-cell transplantation, and significant prognostic impact of donor T-cell chimerism on stable engraftment and progression-fr

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after non-myeloablative conditioning

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Nonmyeloablative stem cell transplantation with CD8-depleted or CD34-selected peripheral blood stem cells

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Engraftment and survival following reduced-intensity allogeneic peripheral blood hematopoietic cell transplantation is affected by CD8+ T-cell dose

1 reference

https://api.crossref.org/works/10.1080%2F10428190601059688

21 January 2018

Identifiers

10.1080/10428190601059688

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17325892%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36746447&oldid=1516153775"